TOMI Environmental Solutions Inc. Common Stock (TOMZ)

FairStock Score: 52/100 — MIXED

Key Financials

AI Analysis

AI-generated, general educational analysis — not personal investment advice.

As a Buffett-Graham investor, I begin with business quality, and here I see a 20-employee disinfection-equipment maker with no obvious durable moat. TOMI sells SteraMist systems into hospitals and medical facilities, but the financial record is that of a struggling small-cap. In fiscal 2023 it reported revenue of $7.4M and a net loss of $3.4M; in fiscal 2024 revenue was $7.7M with a net loss of $4.5M; and in fiscal 2025 revenue fell to $5.6M with a net loss of $3.7M. The latest fiscal Q2 2026, the quarter ended 2026-06-30, showed revenue of $2.2M and a net loss of $382,299, or diluted EPS of -$0.05, which is better than fiscal Q2 2025, when revenue was $1.0M and net loss was $1.2M. Still, fiscal Q1 2026 had revenue of $1.7M and a net loss of $810,645, so one quarter does not prove a turn. At the 2026-10-13 close of $1.65, market cap is $13.4M; FairStock calculations show P/B of 1.18 and P/E of -3.17. FairStock return metrics show ROE of -168.84% and ROCE of -21.04%, confirming poor capital returns. Trailing free cash flow is -$2.1M, with a FairStock FCF yield of -15.8%, and D/E is 2.38; the FairStock Altman Z-score of -8.30 signals financial distress. Piotroski is 5/9 and the FairStock score is 52/100. The Lynch category is none because of losses in each of the last four years. Without a margin of safety in both price and balance sheet, this remains speculative.

In plain English: TOMI Environmental Solutions makes disinfection and decontamination equipment, mainly for hospitals and medical facilities. The business looks weak: it has lost money in recent years and uses cash to operate. The stock price is low, but because the company is not profitable, it does not look like a clear bargain.

The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.

Data as of 2026-10-13 close · note generated 2026-10-15 · model deepseek-flash

Sources (SEC EDGAR): fiscal Q2 2026 10-Q (period ended 2026-06-30) · fiscal Q1 2026 10-Q (period ended 2026-03-31) · fiscal Q3 2025 10-Q (period ended 2025-09-30) · fiscal Q2 2025 10-Q (period ended 2025-06-30) · FY2025 10-K (period ended 2025-12-31) · FY2024 10-K (period ended 2024-12-31) · FY2023 10-K (period ended 2023-12-31)

Fundamentals from company filings and market-data providers; prices are end-of-day, not real-time. AI-generated analysis is general and educational — not personal investment advice. Scoring methodology · Score test · Disclaimer